Katriina Vuolteenaho

Activities

Activities per year 1999 2009 2010 2011 2012 2013 2016 2017 2018 2024

• 164 Conference presentation
• 18 Invited lecture
• 10 Reviewer of Scientific Journal
• 7 Position of trust in an academic community
• 22 More
  • 6 Regular membership of a society or network
  • 4 Pre-examination of dissertation or acting as opponent to doctoral students
  • 4 Supervisor of licentiate candidate in medicine
  • 2 Supervisor of doctoral candidate
  • 2 Supervisor of licentiate candidate
  • 2 Position of trust in a funding organization
  • 1 Statement of assessment of docentship
  • 1 Supervisor of master student

Activities per year

Search results

• Transient receptor potential ankyrin 1 (TRPA1) triggers catabolic and inflammatory effects in human chondrocytes and its expression in downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  27 Apr 2017

  Activity: Talk or presentation › Conference presentation

• High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients

  Vuolteenaho, K. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  27 Apr 2017

  Activity: Talk or presentation › Conference presentation

• High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients

  Vuolteenaho, K. (Contributor), Koskinen-Kolasa, A. (Contributor), Laavola, M. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  22 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate in human chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  22 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes

  Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  27 Jan 2017

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes and mediates cartilage destruction and joint pain in the MIA-model of osteoarthritis

  Nummenmaa, E. (Contributor), Moilanen, L. (Contributor), Hämäläinen, M. (Contributor), Paukkeri, E.-L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  11 Nov 2016

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  31 Mar 2016

  Activity: Talk or presentation › Conference presentation

• TRPA1 mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis

  Moilanen, L. (Contributor), Hämäläinen, M. (Contributor), Nummenmaa, E. (Contributor), Ilmarinen, P. (Contributor), Vuolteenaho, K. (Contributor), Nieminen, R. (Contributor), Lehtimäki, L. (Contributor) & Moilanen, E. (Contributor)

  31 Mar 2016

  Activity: Talk or presentation › Conference presentation

• Adipokines leptin, adiponectin and resistin and their associations to MMPs, IL-6, COMP and radiographic severity of OA

  Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  31 Mar 2016

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human OA chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Paukkeri, E.-L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  16 Mar 2016

  Activity: Talk or presentation › Conference presentation

• YKL-40 is associated with disease activity in early rheumatoid arthritis treated with a combination of DMARDS and infliximab

  Vuolteenaho, K. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  16 Mar 2016

  Activity: Talk or presentation › Conference presentation

• YKL-40 is associated with inflammation and MMPs in osteoarthritis

  Väänänen, T. (Contributor), Hämäläinen, M. (Contributor), Koskinen, A. (Contributor), Paukkeri, E.-L. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  3 Mar 2016

  Activity: Talk or presentation › Conference presentation

• YKL-40 is associated with disease activity in early rheumatoid arthritis treated with a combination of DMARDs and infliximab

  Vuolteenaho, K. (Contributor), Kauppi, M. (Contributor), Moilanen, E. (Contributor) & Nieminen, R. (Contributor)

  11 Feb 2016

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human OA chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Paukkeri, E.-L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  11 Feb 2016

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human OA chondrocytes

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  28 Jan 2016

  Activity: Talk or presentation › Conference presentation

• Adipokines are associated with MMPs, IL-6, COMP and radiographic severity in patients with osteoarthritis

  Koskinen-Kolasa, A. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  28 Jan 2016

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human OA chondrocytes

  Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)

  22 Sept 2015

  Activity: Talk or presentation › Conference presentation

• FGF receptor antagonists show anabolic, anti-catabolic and anti-inflammatory effects in OA cartilage

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  6 Sept 2015

  Activity: Talk or presentation › Conference presentation

• Synthesis of psoralen derivatives and their anti-inflammatory properties. Emerging tarhets and molecules in middle space

  Timonen, J. (Contributor), Vuolteenaho, K. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Aulaskari, P. (Contributor), Jänis, J. (Contributor), Vainiotalo, P. (Contributor) & Moilanen, E. (Contributor)

  24 Aug 2015

  Activity: Talk or presentation › Conference presentation

• Effects of Fibroblast Growth Factor-2 and its Receptor Antagonists in Osteoarthritis

  Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  30 Apr 2015

  Activity: Talk or presentation › Conference presentation

• YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  18 Mar 2015

  Activity: Talk or presentation › Conference presentation

• YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints

  Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  12 Feb 2015

  Activity: Talk or presentation › Conference presentation

• FGF receptor antagonists show anabolic and anti-catabolic effects in OA cartilage

  Nummenmaa, E. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  12 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Vuolteenaho K, Kautiainen H, Tuure , Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi M, Kaipiainen-Seppänen O, High resistin level increases risk for erosive disease in early RA patients treated with a combination of DMARDs (NEO-RACo Study)

  Vuolteenaho, K. (Speaker), Kautiainen, H. (Speaker), Tuure, L. (Speaker), Nieminen, R. (Speaker), Kaitajärvi, T. (Speaker), Hannonen, P. (Speaker), Korpela, M. (Speaker), Kauppi, M. (Speaker), Kaipiainen-Seppänen, O. (Speaker), Luosujärvi, R. (Speaker), Leirisalo-Repo, M. (Speaker) & Moilanen, E. (Speaker)

  29 Jan 2015

  Activity: Talk or presentation › Conference presentation

• FGF receptor antagonists show anabolic and anti-catabolic effects in OA cartilage

  Nummenmaa, E. (Speaker), Moilanen, E. (Speaker) & Vuolteenaho, K. (Speaker)

  29 Jan 2015

  Activity: Talk or presentation › Conference presentation

• YKL-40, a novel marker of disease activity in RA (NEO-RACo Study)

  Vuolteenaho, K. (Speaker), Moilanen, E. (Speaker) & Nieminen, R. (Speaker)

  29 Jan 2015

  Activity: Talk or presentation › Conference presentation

• Endophytic fungi as a source of bioactive compounds

  Sarjala, T. (Contributor), Latva-Mäenpää, H. (Contributor), Savonen, E.-M. (Contributor), Aapola, U. (Contributor), Vuolteenaho, K. (Contributor), Muilu-Mäkelä, R. (Contributor), Tienaho, J. (Contributor), Viitala, K. (Contributor), Lehtimäki, R. (Contributor), Karp, M. (Contributor), Wähälä, K. (Contributor), Uusitalo, H. (Contributor) & Moilanen, E. (Contributor)

  5 Oct 2014

  Activity: Talk or presentation › Conference presentation

• Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD

  Leivo-Korpela, S. (Contributor), Kankaanranta, H. (Contributor), Lehtimäki, L. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  6 Sept 2014

  Activity: Talk or presentation › Conference presentation

• Predictive value of pretreatment resistin levels for erosive disease in early RA treated with DMARDs and infliximab

  Vuolteenaho, K. (Contributor), Kautiainen, H. (Contributor), Möttönen, T. (Contributor), Hannonen, P. (Contributor), Korpela, M. (Contributor), Kauppi, M. (Contributor), Kaipiainen-Seppänen, O. (Contributor), Luosujärvi, R. (Contributor), Nieminen, R. (Contributor), Leirisalo-Repo, M. (Contributor) & Moilanen, E. (Contributor)

  11 Jun 2014

  Activity: Talk or presentation › Conference presentation

• Adipokines in patients with newly diagnosed inflammatory joint diseases

  Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)

  11 Jun 2014

  Activity: Talk or presentation › Conference presentation

• Effects of FGF-2 on MMP-enzymes in osteoarthritic cartilage

  Nummenmaa, E. (Contributor), Moilanen, E. (Contributor), Moilanen, T. (Contributor) & Vuolteenaho, K. (Contributor)

  19 Mar 2014

  Activity: Talk or presentation › Conference presentation

• YKL-40, a NOVEL marker of inflammation, is elevated after coronary artery bypass grafting surgery and correlates with troponin T release

  Laurikka, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor), Tarkka, M. (Contributor) & Vuolteenaho, K. (Contributor)

  19 Mar 2014

  Activity: Talk or presentation › Conference presentation

• Adipokine adiponectin is associated with peripheral obstruction and dynamic hyperinflation and with a favourable response to inhaled glucocorticoids in patients with COPD

  Leivo-Korpela, S. (Contributor), Kankaanranta, H. (Contributor), Lehtimäki, L. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)

  18 Mar 2014

  Activity: Talk or presentation › Conference presentation

• Effects of FGF-2 on MMP-enzymes in OA cartilage

  Nummenmaa, E. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  13 Feb 2014

  Activity: Talk or presentation › Conference presentation

• Effects of FGF-2 on MMP-enzymes in OA cartilage

  Nummenmaa, E. (Speaker), Moilanen, E. (Speaker) & Vuolteenaho, K. (Speaker)

  23 Jan 2014

  Activity: Talk or presentation › Conference presentation

• Catabolic and inflammatory responses of leptin in chondrocytes are regulated by suppressor of cytokine signaling 3

  Koskinen, A. (Speaker), Korhonen, R. (Speaker), Moilanen, E. (Speaker), Moilanen, T. (Speaker) & Vuolteenaho, K. (Speaker)

  8 Nov 2013

  Activity: Talk or presentation › Conference presentation

• Suppressor of Cytokine Signaling 3 Negatively Modulates Leptin-Mediated Catabolic and E. Proinflammatory Effects in Cartilage - New Potential Mechanism to Target Obesity-Induced Osteoarthritis

  Koskinen, A. (Contributor), Korhonen, R. (Contributor), Moilanen, E. (Contributor), Moilanen, T. (Contributor) & Vuolteenaho, K. (Contributor)

  28 Oct 2013

  Activity: Talk or presentation › Conference presentation

• Inflammatory responses to low volume high load and high volume medium load protocols during dynamic leg press exercise

  Räihä, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)

  23 Aug 2013

  Activity: Talk or presentation › Conference presentation

• SOCS-3 expression in the cartilage is reduced in obese patients with osteoarthritis and regulates leptin responses in chondrocytes

  Koskinen, A. (Contributor), Vuolteenaho, K. (Contributor), Korhonen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  20 Apr 2013

  Activity: Talk or presentation › Conference presentation

• Adipocytokine resistin is associated with oxidative stress and myocardial injury in patients undergoing coronary artery bypass surgery

  Laurikka, A. (Contributor), Laurikka, J. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor), Tarkka, M. (Contributor) & Vuolteenaho, K. (Contributor)

  21 Mar 2013

  Activity: Talk or presentation › Conference presentation

• Leptin-induced production of catabolic and pro-inflammatory factors in chondrocytes is regulated by suppressor of cytokine signaling 3

  Koskinen, A. (Contributor), Korhonen, R. (Contributor), Moilanen, E. (Contributor), Moilanen, T. (Contributor) & Vuolteenaho, K. (Contributor)

  21 Mar 2013

  Activity: Talk or presentation › Conference presentation

• Adiponectin in osteoarthritis – a potential target for drug development

  Koskinen, A. (Contributor), Vuolteenaho, K. (Contributor), Juslin, S. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  14 Mar 2013

  Activity: Talk or presentation › Conference presentation

• Leptin-induced production of catabolic and pro-inflammatory factors in chondrocytes is regulated by suppressor of cytokine signaling 3 (SOCS-3)

  Koskinen, A. (Contributor), Vuolteenaho, K. (Contributor), Korhonen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• Adipocytokine resistin is associated with oxidative stress and myocardial injury in patients undergoing coronary artery bypass surgery

  Laurikka, A. (Contributor), Laurikka, J. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor), Tarkka, M. (Contributor) & Vuolteenaho, K. (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• YKL-40 as a factor in osteoarthritis

  Vuolteenaho, K. (Speaker), Väänänen, T. (Speaker), Koskinen, A. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  24 Jan 2013

  Activity: Talk or presentation › Conference presentation

• Suppressor of cytokine signaling 3 is reduced in obese patients with osteoarthritis and regulates leptin responses in chondrocytes

  Koskinen, A. (Speaker), Vuolteenaho, K. (Speaker), Korhonen, R. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  10 Nov 2012

  Activity: Talk or presentation › Conference presentation

• Adipocytokineresistin is associated with myocardial injury in patients undergoing elective coronary artery bypass surgery

  Laurikka, A. (Contributor), Vuolteenaho, K. (Contributor), Toikkanen, V. (Contributor), Leppänen, T. (Contributor), Tarkka, M. (Contributor), Laurikka, J. (Contributor) & Moilanen, E. (Contributor)

  17 Aug 2012

  Activity: Talk or presentation › Conference presentation

• Adiponectin in osteoarthritis – a potential target for drug development

  Koskinen, A. (Contributor), Vuolteenaho, K. (Contributor), Juslin, S. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)

  20 Jul 2012

  Activity: Talk or presentation › Conference presentation

• High leptin concentrations and low SOCS-3 expression are associated with increased MMP levels in patients with osteoarthritis

  Vuolteenaho, K. (Contributor), Koskinen, A. (Contributor), Moilanen, E. (Contributor) & Moilanen, T. (Contributor)

  19 Jul 2012

  Activity: Talk or presentation › Conference presentation

• Adipokines as inflammatory mediators

  Vuolteenaho, K. (Speaker), Koskinen, A. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)

  19 Jul 2012

  Activity: Talk or presentation › Conference presentation